126 related articles for article (PubMed ID: 9864177)
1. Two candidate downstream target genes for E2A-HLF.
Kurosawa H; Goi K; Inukai T; Inaba T; Chang KS; Shinjyo T; Rakestraw KM; Naeve CW; Look AT
Blood; 1999 Jan; 93(1):321-32. PubMed ID: 9864177
[TBL] [Abstract][Full Text] [Related]
2. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.
Dang J; Inukai T; Kurosawa H; Goi K; Inaba T; Lenny NT; Downing JR; Stifani S; Look AT
Mol Cell Biol; 2001 Sep; 21(17):5935-45. PubMed ID: 11486032
[TBL] [Abstract][Full Text] [Related]
3. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
[TBL] [Abstract][Full Text] [Related]
4. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
[TBL] [Abstract][Full Text] [Related]
5. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
[TBL] [Abstract][Full Text] [Related]
6. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
Inukai T; Inaba T; Ikushima S; Look AT
Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120
[TBL] [Abstract][Full Text] [Related]
7. Cell transformation mediated by homodimeric E2A-HLF transcription factors.
Inukai T; Inaba T; Yoshihara T; Look AT
Mol Cell Biol; 1997 Mar; 17(3):1417-24. PubMed ID: 9032268
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
Baudis M; Prima V; Tung YH; Hunger SP
Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
[TBL] [Abstract][Full Text] [Related]
9. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.
Matsunaga T; Inaba T; Matsui H; Okuya M; Miyajima A; Inukai T; Funabiki T; Endo M; Look AT; Kurosawa H
Blood; 2004 Apr; 103(8):3185-91. PubMed ID: 15070701
[TBL] [Abstract][Full Text] [Related]
10. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
Yeung J; O'Sullivan E; Hubank M; Brady HJ
Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
[TBL] [Abstract][Full Text] [Related]
11. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF.
Yoshihara T; Inaba T; Shapiro LH; Kato JY; Look AT
Mol Cell Biol; 1995 Jun; 15(6):3247-55. PubMed ID: 7760820
[TBL] [Abstract][Full Text] [Related]
12. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
[TBL] [Abstract][Full Text] [Related]
13. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
14. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia.
Yamasaki N; Miyazaki K; Nagamachi A; Koller R; Oda H; Miyazaki M; Sasaki T; Honda ZI; Wolff L; Inaba T; Honda H
Oncogene; 2010 Apr; 29(13):1963-75. PubMed ID: 20062079
[TBL] [Abstract][Full Text] [Related]
15. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
Hunger SP; Ohyashiki K; Toyama K; Cleary ML
Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
[TBL] [Abstract][Full Text] [Related]
16. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
Hunger SP; Brown R; Cleary ML
Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
[TBL] [Abstract][Full Text] [Related]
17. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein.
Inukai T; Inoue A; Kurosawa H; Goi K; Shinjyo T; Ozawa K; Mao M; Inaba T; Look AT
Mol Cell; 1999 Sep; 4(3):343-52. PubMed ID: 10518215
[TBL] [Abstract][Full Text] [Related]
18. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
[TBL] [Abstract][Full Text] [Related]
20. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.
Devaraj PE; Foroni L; Sekhar M; Butler T; Wright F; Mehta A; Samson D; Prentice HG; Hoffbrand AV; Secker-Walker LM
Leukemia; 1994 Jul; 8(7):1131-8. PubMed ID: 7518549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
